Bioactivity Assay Development
Bioactivity Assay Development is the systematic design and optimization of analytical methods used to measure the biological activity of chemical compounds during hit-to-lead progression, distinguished by its focus on establishing robust, reproducible, and biologically relevant quantitative readouts that enable structure-activity relationship evaluation and compound prioritization.
145
Publications
9K
Citations
795
Authors
291
Institutions
Publications per year
2017–2026
34
Parents
145
1–5 of 145
795
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 795
291

Chinese Academy of Sciences
Beijing, China
5 h-index
30 publications
818 citations
Nanjing University
Nanjing, China
3 h-index
11 publications
388 citations

National Taiwan University
Taipei, Taiwan
3 h-index
3 publications
53 citations
AbbVie (United States)
North Chicago, United States
2 h-index
3 publications
87 citations

Vertex Pharmaceuticals (United States)
Boston, United States
2 h-index
11 publications
556 citations

Gdańsk Medical University
Gdansk, Poland
2 h-index
5 publications
116 citations

Al-Azhar University
Cairo, Egypt
2 h-index
3 publications
66 citations

Meikai University
Saitama, Japan
2 h-index
3 publications
41 citations
1–8 of 291
8 publications · 433 citations
8
h-index
6 publications · 151 citations
5
h-index
4 publications · 4.1K citations
4
h-index
JCIM · 3 publications · 61 citations
3
h-index
3 publications · 176 citations
3
h-index
1–5